| | Advanced Search

 

Catch Disney on Ice With Your WOO Card—The best places to use your WOO Card…

Paul Giorgio: Mr. Baker, MA Doesn’t Want a Liar for Governor—MA voters deserve a governor that will tell…

Patriots 2014 Schedule Set—The 2014 New England Patriots schedule has officially…

Central MA College Standout: Clark University’s Timothy Conley—Political Science major and track star

Organize + Energize: 4 Ways Getting Organized Will Save You Money—Stop wasting time and money

Patriots’ Day Patriots Primer—In Foxboro, the New England Patriots will begin…

Monfredo: Former Worcester Public School Member Publishes Book—A professional manual for students and professionals

QCC 50th, Celebrating Students: Ato Howard—A Biomedical Engineering student on the rise

MA Beauty Insider: Pedi Nation – Get the Best Pedicure Ever—A guide to finding a pristine pedi place

Fit for Life: Fail to Plan? Plan to Fail—Plan and prioritize, and you will prevail

 
 

HIV + Drug Overdose Linked in RI Hospital Study

Tuesday, December 13, 2011

 

The first research of its kind to look at links between HIV and drug overdose.

HIV-infected individuals are at substantial risk for drug overdose, according to new research from Rhode Island Hospital, the first study to systematically review and analyze the literature on the association between HIV infection and overdose risk.

The findings show a 74 percent greater risk of overdose among drug users if they are HIV-infected. The researchers found that reasons for the increased risk are biological and behavioral, but may also include environmental and structural factors. The study is now available online in advance of print in the journal AIDS.

Heightened risks on all sides

Drug overdose is a common cause of non-AIDS death among people with HIV and is the leading cause of death for people who inject drugs. People with HIV are often exposed to opioid medication as part of their treatment, while others may continue to use illicit opioids despite their disease status. Both scenarios present a heightened risk for fatal and non-fatal overdose. While the association between HIV infection and injection drug use has been well documented, the potential association between HIV and overdose has received less attention.

With this in mind, Traci Green, Ph.D., M.Sc., a researcher with Rhode Island Hospital and the Lifespan/Tufts/Brown Center for AIDS Research, led a study to systematically review the literature on the putative association of HIV infection with overdose, meta-analyze the results and explore the causes.

Premature death for HIV-infected

Green reports that 46 studies were reviewed, and 24 of those reported data that were sufficient for inclusion in their analysis. Based on those studies, Green says, “Our results suggest that people who use drugs have a 74 percent greater risk of overdose if they are HIV-infected compared to their counterparts who are not HIV-infected.  Over the past 30 years, we have made impressive strides in caring for and prolonging the lives of people with HIV.  Our study found that premature death by overdose is an issue that affects people with HIV disproportionately.”

Searching for why

“It is not entirely clear why the risk is greater, and few studies have endeavored to figure out why this might be happening,” Green points out. Biological explanations for the association could include clinical status, immunosuppression, opportunistic infections and poorer physical health in this population, while several studies posit that conditions that affect body’s ability to metabolize, like hepatitis C infection,  may also increase the risk of overdose. Behavioral factors include high-risk lifestyles and psychiatric comorbidities that might be greater among HIV-infected than HIV-uninfected drug users.

Green further explains that other reasons for the association may include factors such as poor access to medication-assisted therapy to treat opioid dependence, homelessness and poverty, which may contribute to a higher risk of overdose.

Reducing risk

Through their research, Green reports that there are ways to reduce the increased risk of overdose among this population. Green comments, “The good news is that we already have several cost-effective overdose prevention tools to call upon.  The first is access to highly active antiretroviral therapy (HAART) medications, prescribed by providers prepared to prevent and manage potential interactions between antiretrovirals and drugs with abuse potential. The second is medication-assisted therapy, and in particular, methadone and buprenorphine therapies, which have been shown to protect against fatal overdose. The third tool is distribution of Naloxone (Narcan), a prescription medication with no abuse potential that reverses an opioid overdose, to people who are HIV positive and use opiates.  

Green adds, “Bringing overdose awareness and prevention into the HIV care setting is critical to reducing overdose deaths.  Health care providers who treat HIV-infected patients with a history of substance abuse or who are taking opioid medications should consider counseling patients on how to reduce their risk of overdose. They may also consider prescribing Naloxone to patients, or offering a referral to MAT to reduce the risk of overdose.”

The study was funded through grants from the Centers for Disease Control and Prevention, the National Institutes of Health (NIH), National Institute on Drug Abuse and the NIH Center for AIDS Research.

 

Related Articles

 

Enjoy this post? Share it with others.




Write your comment...

You must be logged in to post comments.